Page last updated: 2024-08-26

s-nitrosoglutathione and Coronary Disease

s-nitrosoglutathione has been researched along with Coronary Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, AS; de Belder, AJ; Langford, EJ; Martin, JF; Moncada, S; Radomski, MW; Smith, RE; Thomas, MR; Wainwright, RJ1
de Belder, AJ; Langford, EJ; Marrinan, MT; Martin, JF; Moncada, S; Salas, E1
Campanella, C; Megson, IL; Sogo, N; Webb, DJ1

Trials

2 trial(s) available for s-nitrosoglutathione and Coronary Disease

ArticleYear
Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty.
    Lancet (London, England), 1994, Nov-26, Volume: 344, Issue:8935

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Female; Glutathione; Heparin; Humans; Male; Middle Aged; Nitroglycerin; Nitroso Compounds; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Recurrence; S-Nitrosoglutathione

1994
S-nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo.
    Heart (British Cardiac Society), 1998, Volume: 80, Issue:2

    Topics: Aged; Antibodies, Monoclonal; Coronary Artery Bypass; Coronary Disease; Female; Glutathione; Graft Occlusion, Vascular; Humans; Indium Radioisotopes; Male; Middle Aged; Myocardial Revascularization; Nitroso Compounds; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; Saphenous Vein

1998

Other Studies

1 other study(ies) available for s-nitrosoglutathione and Coronary Disease

ArticleYear
S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.
    British journal of pharmacology, 2000, Volume: 131, Issue:6

    Topics: Acetylcholine; Coronary Artery Bypass; Coronary Disease; Enzyme Inhibitors; Glucosamine; Glutathione; Humans; Mammary Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroso Compounds; Penicillamine; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; Saphenous Vein; Vasodilation; Vasodilator Agents

2000